{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:25:50Z","timestamp":1777699550527,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.semnephrol.2011.09.005","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T02:52:48Z","timestamp":1321671168000},"page":"503-512","source":"Crossref","is-referenced-by-count":28,"title":["Use of Diuretics in Heart Failure and Cirrhosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Robert W.","family":"Schrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2011.09.005_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.4.1.85","article-title":"Evidence of atrial location of receptors in influencing urine flow","volume":"4","author":"Henry","year":"1956","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib2","series-title":"Atrial receptors","author":"Linden","year":"1982"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib3","series-title":"Atrial hormones and other natriuretic factors","article-title":"Clinical physiology series","year":"1987"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-113-2-155","article-title":"Body fluid volume regulation in health and disease: a unifying hypothesis","volume":"113","author":"Schrier","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.RES.37.1.101","article-title":"Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat","volume":"37","author":"Myers","year":"1975","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM197112022852305","article-title":"Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate","volume":"285","author":"Schrier","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib8","first-page":"721","article-title":"Peripheral arterial vasodilation hypothesis: implications for impaired aldosterone escape","volume":"3","author":"Schrier","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-96-4-413","article-title":"Role of vasopressin in abnormal water excretion in cirrhotic patients","volume":"96","author":"Bichet","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib11","first-page":"1","article-title":"National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data","volume":"158","author":"Kozak","year":"2005","journal-title":"Vital Health Stat 13"},{"issue":"Suppl B","key":"10.1016\/j.semnephrol.2011.09.005_bib12","first-page":"B131","article-title":"Reassessing treatment of acute heart failure syndromes: the ADHERE registry","volume":"7","author":"Gheorghiade","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations form the first 100,000 cases in the Acute Decompensated Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","article-title":"Congestion in acute heart failure syndromes: an essential target of evaluation and treatment","volume":"119","author":"Gheorghiade","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2215\/CJN.01410210","article-title":"Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome","volume":"5","author":"Schrier","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semnephrol.2011.09.005_bib19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])","volume":"78","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)","volume":"118","author":"Pitt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.V1271335","article-title":"Loop diuretic infusion increases thiazide-sensitive Na+-Cl- cotransporter abundance: role of aldosterone","volume":"12","author":"Abdallah","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000417488","article-title":"Effects of ultrafiltration of body fluid and transcapillary colloid osmotic gradient in hemodialysis patients, improvements in dialysis therapy","volume":"74","author":"Fauchauld","year":"1989","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib23","series-title":"Heart failure: a practical approach to therapy","first-page":"91","article-title":"How to use diuretics in heart failure patients","author":"Schrier","year":"2007"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrneph.2010.52","article-title":"Hyperkalemia: a threat to RAAS inhibition?","volume":"6","author":"Schrier","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib26","doi-asserted-by":"crossref","first-page":"c1768","DOI":"10.1136\/bmj.c1768","article-title":"Spironolactone use and renal toxicity: population based longitudinal analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.32.2.223","article-title":"A method for the detection and quantification of impaired sodium excretion","volume":"32","author":"Braunwald","year":"1965","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib28","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000168356","article-title":"Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention","volume":"11","author":"Hensen","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib31","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7326\/0003-4819-94-2-198","article-title":"Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites","volume":"94","author":"Arroyo","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib34","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib36","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1172\/JCI626","article-title":"Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites","volume":"101","author":"Martin","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0016-5085(19)32136-5","article-title":"Complications of diuresis in the alcoholic patient with ascites: a controlled trial","volume":"73","author":"Gregory","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib42","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2011.09.005_bib44","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pag\u00e1n","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511001343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511001343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T04:52:39Z","timestamp":1639716759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929511001343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0270929511001343"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2011.09.005","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}